Urban Health Weekly

Urban Health Weekly

By Urban Health WeeklyMedicineHealth & Fitness
Download on the App Store

Urban Health Weekly episodes

  • Food Myths - Episode #108
    Tamara Thomas and Dr. Monique Nugent tackle whether the popular saying "If you can't pronounce it, don't eat it," still holds value for mindful eating.

    Hosted on Acast. See acast.com/privacy for more information.

    55 min
  • Interviews with Key Healthcare Opinion Leaders - Episode #107
    Cory Rice, DO, a practitioner specializing in Functional Medicine and anti-aging medicine, and Chief Clinical Advisor for Biote Medical, talks about the next steps for patients who have discontinued GLP-1s but still require assistance with reversing their health conditions.

    Hosted on Acast. See acast.com/privacy for more information.

    33 min
  • Interviews with Key Healthcare Opinion Leaders - Episode #106
    Dr. Alessandra Maleddu, a Medical Oncologist and Sarcoma Specialist at the University of Colorado, talks about desmoid tumors. She highlights methods for enhancing patient diagnosis through imaging techniques and the importance of referring patients to a sarcoma specialist.

    Hosted on Acast. See acast.com/privacy for more information.

    13 min
  • Conversations with Patient Advocates - Episode #105
    After years of misdiagnoses and, later, infertility, April Christina was diagnosed with stage four endometriosis. She talks about the challenges of getting properly diagnosed as a Black woman, the emotional toll of infertility, and her experience with IVF. April Christina also emphasizes the importance of support systems, faith, and advocacy, as well as the resources available through Fertility Out Loud.

    Hosted on Acast. See acast.com/privacy for more information.

    28 min
  • Interviews with Key Healthcare Opinion Leaders - Episode #103
    Dr. Andrew Hertler, Senior Advisor / Chief Medical Officer – emeritus for Evolent, explains ODAC’s September 2024 vote to support the FDA’s decision to restrict the use of PD-1 inhibitor drugs such as Opdivo, Keytruda, and Tevimbra for PD-L1-negative stomach cancer and esophageal cancer, and his support of using biomarkers to predict outcomes.

    Hosted on Acast. See acast.com/privacy for more information.

    44 min
  • Interviews with Key Healthcare Opinion Leaders – Episode #100
    Terra Wonsettler, PharmD, Vice President of Clinical Evidence, Policy, and Oncology Pharmacy at Evolent, discusses the cardiotoxicity of many cancer drugs, cancer patient awareness of these risks, and the accelerated cancer drug approval process.

    Hosted on Acast. See acast.com/privacy for more information.

    28 min

About Urban Health Weekly

From the publisher's feed

The Urban Health Weekly Podcast: Medical News That Matters to You

Hosted on Acast. See acast.com/privacy for more information.